{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:10:25Z","timestamp":1795201825263,"version":"4.10.3"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020M3A9I4039539"],"award-info":[{"award-number":["NRF-2020M3A9I4039539"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3A9G8083382"],"award-info":[{"award-number":["2017M3A9G8083382"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A5A2021614"],"award-info":[{"award-number":["NRF-2021R1A5A2021614"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biomaterials.2021.121137","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T12:25:07Z","timestamp":1631881507000},"page":"121137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":481,"special_numbering":"C","title":["M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages"],"prefix":"10.1016","volume":"278","author":[{"given":"Gowri Rangaswamy","family":"Gunassekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Murugan","family":"Poongkavithai Vadevoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Chang","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4561-1027","authenticated-orcid":false,"given":"Byungheon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2021.121137_bib1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib3","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.180.4.2011","article-title":"Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms","volume":"180","author":"Biswas","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.biomaterials.2021.121137_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12943-019-1102-3","article-title":"Harnessing tumor-associated macrophages as aids for cancer immunotherapy","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Canc."},{"key":"10.1016\/j.biomaterials.2021.121137_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2021.121137_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","article-title":"Differential macrophage programming in the tumor microenvironment","volume":"33","author":"Ruffell","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2021.121137_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","article-title":"The role of tumour\u2010associated macrophages in tumour progression: implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib12","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor-associated macrophage in pancreatic cancer","volume":"167","author":"Kurahara","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"Andaloussi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2021.121137_bib14","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1021\/acs.molpharmaceut.8b00277","article-title":"Exosomes as a drug delivery system in cancer therapy: potential and challenges","volume":"15","author":"Kibria","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2021.121137_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/nar\/gks463","article-title":"Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes","volume":"40","author":"Wahlgren","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib16","doi-asserted-by":"crossref","first-page":"30110","DOI":"10.1038\/srep30110","article-title":"Pancreatic cancer cell exosome-mediated macrophage reprogramming and the role of MicroRNAs 155 and 125b2 transfection using nanoparticle delivery systems","volume":"6","author":"Su","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2021.121137_bib17","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ymthe.2017.02.007","article-title":"Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node","volume":"25","author":"Cheng","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2021.121137_bib18","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.7150\/thno.30716","article-title":"Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2021.121137_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/nn404945r","article-title":"Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter","volume":"8","author":"Lai","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2021.121137_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbiotec.2013.03.013","article-title":"Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection","volume":"165","author":"Takahashi","year":"2013","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib21","doi-asserted-by":"crossref","first-page":"26316","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biomaterials.2021.121137_bib22","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/s41467-018-04791-8","article-title":"Efficient RNA drug delivery using red blood cell extracellular vesicles","volume":"9","author":"Usman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2021.121137_bib23","doi-asserted-by":"crossref","first-page":"26238","DOI":"10.3402\/jev.v4.26238","article-title":"Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice","volume":"4","author":"Imai","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biomaterials.2021.121137_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/mt.2012.180","article-title":"Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells","volume":"21","author":"Ohno","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2021.121137_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","article-title":"Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system","volume":"132","author":"LaPorte","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2021.121137_bib27","first-page":"3503","article-title":"Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy","volume":"8","author":"Kawakami","year":"2002","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03402112","article-title":"Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo","volume":"6","author":"Leland","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.biomaterials.2021.121137_bib29","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1245\/s10434-017-5907-2","article-title":"Elevated interleukin-13 receptor alpha 1 expression in tumor cells is associated with poor prognosis in patients with invasive breast cancer","volume":"24","author":"Park","year":"2017","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib31","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","article-title":"Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes","volume":"70","author":"Movahedi","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/2326-6066.CIR-14-0232","article-title":"TH2-Polarized CD4(+) T cells and macrophages limit efficacy of radiotherapy","volume":"3","author":"Shiao","year":"2015","journal-title":"Canc. Immunol. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib33","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1158\/1535-7163.MCT-17-0339","article-title":"Interleukin 4 receptor-targeted pro-apoptotic peptide blocks tumor growth and metastasis by enhancing anti-tumor immunity","author":"Vadevoo","year":"2017","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.biomaterials.2021.121137_bib34","doi-asserted-by":"crossref","first-page":"11432","DOI":"10.1158\/0008-5472.CAN-06-1867","article-title":"p50 nuclear factor-\u03baB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance","volume":"66","author":"Saccani","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.celrep.2011.12.005","article-title":"miR-511-3p modulates genetic programs of tumor-associated macrophages","volume":"1","author":"Squadrito","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2021.121137_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.it.2013.02.003","article-title":"MicroRNA-mediated control of macrophages and its implications for cancer","volume":"34","author":"Squadrito","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jconrel.2015.05.260","article-title":"Enhanced delivery of liposomes to lung tumor through targeting interleukin-4 receptor on both tumor cells and tumor endothelial cells","volume":"209","author":"Chi","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2021.121137_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biomaterials.2017.07.024","article-title":"Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth","volume":"142","author":"Guruprasath","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2021.121137_bib39","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1038\/ncomms4702","article-title":"Poly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapy","volume":"5","author":"Namgung","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2021.121137_bib40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/bp0342093","article-title":"Rapid protein anchoring into the membranes of Mammalian cells using oleyl chain and poly(ethylene glycol) derivatives","volume":"20","author":"Kato","year":"2004","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biomaterials.2021.121137_bib41","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-17-3480","article-title":"Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner","volume":"78","author":"Wanderley","year":"2018","journal-title":"Canc. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1541-7786.MCR-18-0891","article-title":"Internalization of exosomes through receptor-mediated endocytosis","volume":"17","author":"Gonda","year":"2019","journal-title":"Mol. Canc. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib43","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.5301\/ijbm.5000280","article-title":"High expression of IL-4R enhances proliferation and invasion of hepatocellular carcinoma cells","volume":"32","author":"Guo","year":"2017","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.biomaterials.2021.121137_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1020134521778","article-title":"Liposome clearance","volume":"22","author":"Ishida","year":"2002","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biomaterials.2021.121137_bib45","doi-asserted-by":"crossref","first-page":"26238","DOI":"10.3402\/jev.v4.26238","article-title":"Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice","volume":"4","author":"Imai","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biomaterials.2021.121137_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/1061186X.2014.880443","article-title":"Tumour-associated macrophages targeted transfection with NF-\u03baB decoy\/mannose-modified bubble lipoplexes inhibits tumour growth in tumour-bearing mice","volume":"22","author":"Kono","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biomaterials.2021.121137_bib47","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.7150\/thno.30305","article-title":"Rho-associated coiled-coil kinase (ROCK) in molecular regulation of angiogenesis","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2021.121137_bib48","first-page":"2632","article-title":"Significant association of Rho\/ROCK pathway with invasion and metastasis of bladder cancer","volume":"9","author":"Kamai","year":"2003","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib49","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/labinvest.3700674","article-title":"ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging","volume":"87","author":"Vishnubhotla","year":"2007","journal-title":"Lab. Invest."},{"key":"10.1016\/j.biomaterials.2021.121137_bib50","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hep.22836","article-title":"Rho\u2010kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion","volume":"49","author":"Wong","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2021.121137_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biomaterials.2018.01.013","article-title":"Non-genetic engineering of cytotoxic T cells to target IL-4 receptor enhances tumor homing and therapeutic efficacy against melanoma","volume":"159","author":"Gunassekaran","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2021.121137_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0195","article-title":"Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy","volume":"10","author":"Gao","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2021.121137_bib53","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.7150\/thno.45028","article-title":"Engineering blood exosomes for tumor-targeting efficient gene\/chemo combination therapy","volume":"10","author":"Zhan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2021.121137_bib54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2021.121137_bib55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1359-6446(04)03104-6","article-title":"Phage display-derived peptides as therapeutic alternatives to antibodies","volume":"9","author":"Ladner","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2021.121137_bib56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2021.121137_bib57","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2021.121137_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2567.2006.02366.x","article-title":"Tumoristatic effects of anti\u2010CD40 mAb\u2010activated macrophages involve nitric oxide and tumour necrosis factor\u2010\u03b1","volume":"118","author":"Lum","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.biomaterials.2021.121137_bib59","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","article-title":"Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis","volume":"15","author":"Georgoudaki","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2021.121137_bib60","first-page":"4750","article-title":"High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules","volume":"61","author":"Adams","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.biomaterials.2021.121137_bib61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1479-5876-9-216","article-title":"Identification and manipulation of tumor associated macrophages in human cancers","volume":"9","author":"Heusinkveld","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biomaterials.2021.121137_bib62","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2021.121137_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/2326-6066.CIR-14-0226","article-title":"Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatment","volume":"3","author":"Zippelius","year":"2015","journal-title":"Canc. Immunol. Res."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221004944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221004944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:02:52Z","timestamp":1777485772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961221004944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":63,"alternative-id":["S0142961221004944"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121137","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121137"}}